IPCALAB

Ipca Laboratories Share Price

₹1,573.55 -0.95 (-0.06%)

21 Nov, 2024 15:46

SIP TrendupStart SIP in IPCALAB

Start SIP

Performance

  • Low
  • ₹1,554
  • High
  • ₹1,588
  • 52 Week Low
  • ₹1,041
  • 52 Week High
  • ₹1,709
  • Open Price₹1,570
  • Previous Close₹1,575
  • Volume151,571

Investment Returns

  • Over 1 Month -4.62%
  • Over 3 Month + 13.67%
  • Over 6 Month + 20.14%
  • Over 1 Year + 48.34%
SIP Lightning

Smart Investing Starts Here Start SIP with Ipca Laboratories for Steady Growth!

Invest Now

Ipca Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 60.4
  • PEG Ratio
  • 1.8
  • Market Cap Cr
  • 39,922
  • P/B Ratio
  • 5.2
  • Average True Range
  • 50.45
  • EPS
  • 26.47
  • Dividend Yield
  • 0.3
  • MACD Signal
  • 5.5
  • RSI
  • 52.31
  • MFI
  • 64.91

Ipca Laboratories Financials

Ipca Laboratories Technicals

EMA & SMA

Current Price
₹1,573.55
-0.95 (-0.06%)
pointer
  • stock-down_img
  • Bullish Moving Average 15
  • stock-up_img
  • Bearish Moving Average 1
  • 20 Day
  • ₹1,564.63
  • 50 Day
  • ₹1,528.56
  • 100 Day
  • ₹1,451.22
  • 200 Day
  • ₹1,338.40

Resistance and Support

1579.02 Pivot Speed
  • R3 1,653.03
  • R2 1,629.87
  • R1 1,602.18
  • S1 1,551.33
  • S2 1,528.17
  • S3 1,500.48

What's your outlook on Ipca Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ipca Laboratories Ltd. is a global pharmaceutical company, producing over 350 formulations and 80 APIs. Operating in 120+ countries, it leads in therapeutic areas like pain, rheumatology, and antimalarials, with fully-automated facilities approved by global regulatory bodies.

Ipca Laboratories has an operating revenue of Rs. 8,533.40 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 11% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 19% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 71 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 36 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ipca Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results & Interim Dividend
2024-09-30 Others
2024-08-13 Quarterly Results
2024-05-29 Audited Results & Final Dividend
2024-02-14 Quarterly Results
Date Purpose Remarks
2024-11-25 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
2023-11-22 INTERIM Rs.2.00 per share(200%)Interim Dividend (Revised)
2022-11-23 INTERIM Rs.4.00 per share(400%)Interim Dividend
2021-11-23 INTERIM Rs.8.00 per share(400%)Interim Dividend
Date Purpose Remarks
2022-01-11 Split Rs.0.00 split from Rs. 2/- to Re. 1/-.

Ipca Laboratories F&O

Ipca Laboratories Shareholding Pattern

46.3%
28.55%
4.87%
10.83%
0%
6.93%
2.52%

About Ipca Laboratories

  • NSE Symbol
  • IPCALAB
  • BSE Symbol
  • 524494
  • Managing Director
  • Mr. Ajit Kumar Jain
  • ISIN
  • INE571A01038

Similar Stocks to Ipca Laboratories

Ipca Laboratories FAQs

Ipca Laboratories share price is ₹1,573 As on 21 November, 2024 | 15:32

The Market Cap of Ipca Laboratories is ₹39921.6 Cr As on 21 November, 2024 | 15:32

The P/E ratio of Ipca Laboratories is 60.4 As on 21 November, 2024 | 15:32

The PB ratio of Ipca Laboratories is 5.2 As on 21 November, 2024 | 15:32

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23